🟢 4DMedical is trading 5.1% up today despite no specific catalyst identified

4DMedical is trading 5.08% up now at A$3.72 after no specific September 16, 2026 company catalyst was identified.

• An investor presentation featuring CEO Andreas Fouras is scheduled for September 17, 2026.
• MarketScreener also lists an earnings presentation for September 17, 2026, but no results-driven announcement was found.
• Broader U.S. markets were broadly flat, providing no strong market-wide explanation.